D
David N. Finegold
Researcher at University of Pittsburgh
Publications - 97
Citations - 9278
David N. Finegold is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Lymphedema & Gene. The author has an hindex of 43, co-authored 93 publications receiving 8569 citations. Previous affiliations of David N. Finegold include Boston Children's Hospital & Indira Gandhi Centre for Atomic Research.
Papers
More filters
Journal ArticleDOI
Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor
Tatiana V. Petrova,Taija Makinen,Tomi P. Mäkelä,Janna Saarela,Ismo Virtanen,Robert E. Ferrell,David N. Finegold,Dontscho Kerjaschki,Seppo Ylä-Herttuala,Kari Alitalo +9 more
TL;DR: It is found that isolated human primary lymphatic and blood vascular endothelial cells show interesting differences in gene expression relevant for their distinct functions in vivo, and overexpression of the homeobox transcription factor Prox‐1 in the BECs is suggested to act as a cell proliferation inducer and a fate determination factor for the LECs.
Journal ArticleDOI
Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema
Marika J. Karkkainen,Robert E. Ferrell,Elizabeth C. Lawrence,Mark A. Kimak,Kara L. Levinson,Michele A. McTigue,Kari Alitalo,David N. Finegold +7 more
TL;DR: It is established that VEGFR-3 is important for normal lymphatic vascular function and that mutations interfering with VEGfr-3 signal transduction are a cause of primary lymphoedema.
Journal ArticleDOI
A model for gene therapy of human hereditary lymphedema
Marika J. Karkkainen,Anne Saaristo,Lotta Jussila,Kaisa Karila,Elizabeth C. Lawrence,Katri Pajusola,Hansruedi Büeler,Anne Eichmann,Risto A. Kauppinen,Mikko I. Kettunen,Seppo Ylä-Herttuala,David N. Finegold,Robert E. Ferrell,Kari Alitalo +13 more
TL;DR: By using virus-mediated VEGF-C gene therapy, the results suggest that growth factor gene therapy is applicable to human lymphedema and provide a paradigm for other diseases associated with mutant receptors.
Journal ArticleDOI
Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis
Tatiana V. Petrova,Terhi Karpanen,Camilla Norrmén,Russell H. Mellor,Tomoki Tamakoshi,David N. Finegold,Robert E. Ferrell,Dontscho Kerjaschki,Peter Mortimer,Seppo Ylä-Herttuala,Naoyuki Miura,Kari Alitalo +11 more
TL;DR: The data show that Foxc2 is essential for the morphogenesis of lymphatic valves and the establishment of a pericyte-free lymphatic capillary network and that it cooperates with Vegfr3 in the latter process.
Journal ArticleDOI
Photonic Crystal Carbohydrate Sensors: Low Ionic Strength Sugar Sensing
Sanford A. Asher,Vladimir L. Alexeev,Alexander V. Goponenko,Anjal C. Sharma,Igor K. Lednev,Craig S. Wilcox,David N. Finegold +6 more
TL;DR: A carbohydrate sensing material, which consists of a crystalline colloidal array (CCA) incorporated into a polyacrylamide hydrogel with pendent boronic acid groups, which responds to species containing vicinal cis diols such as carbohydrates.